DK3349763T3 - Composition for use in microbiota modulation - Google Patents

Composition for use in microbiota modulation Download PDF

Info

Publication number
DK3349763T3
DK3349763T3 DK16845808.1T DK16845808T DK3349763T3 DK 3349763 T3 DK3349763 T3 DK 3349763T3 DK 16845808 T DK16845808 T DK 16845808T DK 3349763 T3 DK3349763 T3 DK 3349763T3
Authority
DK
Denmark
Prior art keywords
composition
microbiota modulation
microbiota
modulation
Prior art date
Application number
DK16845808.1T
Other languages
English (en)
Inventor
Bruce Mcconnell
Louise Kristine Vigsnæs
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom As filed Critical Glycom As
Application granted granted Critical
Publication of DK3349763T3 publication Critical patent/DK3349763T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK16845808.1T 2015-09-14 2016-09-14 Composition for use in microbiota modulation DK3349763T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201570589 2015-09-14
DKPA201670098 2016-02-24
PCT/IB2016/055466 WO2017046711A1 (en) 2015-09-14 2016-09-14 Synthetic composition for microbiota modulation

Publications (1)

Publication Number Publication Date
DK3349763T3 true DK3349763T3 (en) 2021-11-15

Family

ID=58288193

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16845808.1T DK3349763T3 (en) 2015-09-14 2016-09-14 Composition for use in microbiota modulation

Country Status (6)

Country Link
US (2) US10751354B2 (da)
EP (1) EP3349763B1 (da)
DK (1) DK3349763T3 (da)
ES (1) ES2886951T3 (da)
PL (1) PL3349763T3 (da)
WO (1) WO2017046711A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2451462T3 (da) 2009-07-06 2017-12-11 Children's Hospital Medical Center Hæmning af inflammation med mælkeoligosaccharider
CN115364113A (zh) 2014-10-29 2022-11-22 格礼卡姆股份公司 合成组合物以及用于治疗肠易激综合症的方法
US11040049B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3288389A4 (en) 2015-04-28 2018-10-10 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
WO2018157900A1 (en) 2017-03-01 2018-09-07 Glycom A/S Synthetic composition for microbiota modulation
CN110730665A (zh) * 2017-04-07 2020-01-24 儿童医院医疗中心 用2’-岩藻糖基乳糖化合物治疗炎症性肠病
WO2018207110A1 (en) * 2017-05-09 2018-11-15 Glycom A/S Synthetic composition for microbiota modulation
EP3630124A4 (en) * 2017-05-24 2021-02-24 Glycom A/S SYNTHETIC COMPOSITION CONSISTING OF OLIGOSACCHARIDES AND ITS USE IN MEDICAL TREATMENT
WO2019106618A1 (en) * 2017-11-30 2019-06-06 Glycom A/S Mixture of hmos for treating wheat sensitivity
EP3716983A4 (en) * 2017-11-30 2022-03-02 Glycom A/S HUMAN MILK OLIGOSACCHARIDES AND SYNTHETIC COMPOSITIONS THEREOF FOR MICROBIOTA MODULATION
CN111491638A (zh) * 2017-12-21 2020-08-04 雀巢产品有限公司 用于在婴儿和幼儿中促进消化能力的包含至少一种n-乙酰化低聚糖和至少一种岩藻糖基化低聚糖的组合物
US11484547B2 (en) * 2018-01-08 2022-11-01 Performance Labs PTE. LTD. Compositions and methods for cholesterol, glucose and microbiome control
GB201806941D0 (en) * 2018-04-27 2018-06-13 Ip Science Ltd Methods for improving the microbiome and its systemic effect
BR112020022892A2 (pt) * 2018-05-31 2021-02-23 Glycom A/S mistura de hmos para tratamento de doenças autoi-munes
MX2021005975A (es) 2018-12-21 2021-07-15 Nestle Sa Una composicion nutricional que comprende 6'sl y lnt en combinacion para mejorar la funcion de la barrera gastrointestinal.
MX2021006189A (es) 2018-12-21 2021-06-23 Nestle Sa Una composicion nutricional que comprende 2'-fucasillactosa (2'fl) para mejorar la barrera gastrointestinal.
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
WO2020174386A1 (en) * 2019-02-25 2020-09-03 Nutribam Bvba Composition, food supplement and method for supporting and/or improving intestinal health
WO2020239724A1 (en) * 2019-05-29 2020-12-03 Frieslandcampina Nederland B.V. Compositions comprising 2 -fucosyllactose and gos
EP3976052A1 (en) * 2019-05-29 2022-04-06 FrieslandCampina Nederland B.V. Non-therapeutic methods for maintaining a healthy body weight or losing body weight
BR112021024149A2 (pt) * 2019-06-05 2022-02-08 Glycom As Oligossacarídeos de leite humano para uso no tratamento de sintomas em um paciente sofrendo de sensibilidade não celíaca ao trigo e/ou glúten
EP4058031A4 (en) * 2019-11-14 2023-11-08 Glycom A/S SYNTHETIC COMPOSITION FOR BALANCING THE BALE ACID PROFILE IN THE INTESTINAL
CN112870233A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 包含乳双歧杆菌与母乳低聚糖的组合物及其应用
CN115297878A (zh) * 2020-03-16 2022-11-04 米佳利斯有限公司 用于增强人受试者中尿石素产生的组合物
CA3210075A1 (en) 2021-04-13 2022-10-20 Petronella Johanna Looijesteijn Nutritional composition for stimulationg bifidobacteria

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227777A (ja) * 1985-04-02 1986-10-09 Showa Sangyo Kk ビフイズス菌生育活性剤
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
DK1991690T3 (da) 2006-03-09 2014-04-14 Centre Nat Rech Scient Fremgangsmåde til fremstilling af sialylerede oligosaccharider
EP2405918B2 (en) * 2009-03-13 2020-09-02 The Regents of The University of California Prebiotic oligosaccharides
US9012625B2 (en) 2009-04-07 2015-04-21 Glycom A/S Method for the synthesis of a trisaccharide
US9237764B2 (en) 2010-02-19 2016-01-19 Glycom A/S Production of 6′-O-sialyllactose and intermediates
WO2011100980A1 (en) 2010-02-19 2011-08-25 Glycom A/S A method for preparation of the tetrasaccharide lacto-n-neotetraose (lnnt) containing n-acetyllactosamine
RU2013106896A (ru) 2010-07-16 2014-08-27 Глюком А/С Синтез новых производных сиалоолигосахаридов
CA3038073C (en) * 2010-12-31 2021-05-25 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
CN103501638A (zh) * 2010-12-31 2014-01-08 雅培制药有限公司 包含人乳低聚糖和核苷酸的营养型组合物以及其治疗和/或预防肠病毒感染的用途
MX356184B (es) * 2010-12-31 2018-05-17 Abbott Lab Fórmulación pediátrica sintética que comprende un probiótico.
CA2827294A1 (en) 2011-02-21 2012-08-30 Glycom A/S Catalytic hydrogenolysis of a composition of a mixture of oligosaccharide precursors and uses thereof
WO2012127410A1 (en) 2011-03-18 2012-09-27 Glycom A/S Synthesis of new fucose-containing carbohydrate derivatives
JP6106160B2 (ja) 2011-05-13 2017-03-29 グリコム アー／エスＧｌｙｃｏｍ Ａ／Ｓ 人乳オリゴ糖（ｈｍｏ）又はその前駆体の多様化
CN103703012A (zh) 2011-05-13 2014-04-02 格礼卡姆股份公司 乳糖-n-四糖的制造
CA2835986A1 (en) 2011-05-13 2012-11-22 Glycom A/S Method for generating human milk oligosaccharides (hmos) or precursors thereof
CA2846603A1 (en) * 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN103958537A (zh) 2011-09-30 2014-07-30 格礼卡姆股份公司 Hmo核心结构的合成
BR112014008657A2 (pt) 2011-10-18 2017-04-25 Nestec Sa composição para o uso em aumentar a sensibilidade à insulina e/ou reduzir a resistência à insulina
US20150087616A1 (en) 2011-11-30 2015-03-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
US20150065702A1 (en) 2012-03-20 2015-03-05 Glycom A/S Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof
US10624916B2 (en) 2012-12-20 2020-04-21 Abbott Laboratories Nutritional formulations using human milk oligosaccharides for modulating inflammation
US10165788B2 (en) * 2013-06-17 2019-01-01 The Regents Of The University Of California Methods and compositions for improved digestion of milk oligosaccharides
CN115364113A (zh) * 2014-10-29 2022-11-22 格礼卡姆股份公司 合成组合物以及用于治疗肠易激综合症的方法

Also Published As

Publication number Publication date
EP3349763A1 (en) 2018-07-25
US10751354B2 (en) 2020-08-25
ES2886951T3 (es) 2021-12-21
EP3349763A4 (en) 2019-05-01
PL3349763T3 (pl) 2022-01-03
EP3349763B1 (en) 2021-08-11
WO2017046711A1 (en) 2017-03-23
US11696921B2 (en) 2023-07-11
US20210000848A1 (en) 2021-01-07
US20180185396A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
DK3349763T3 (en) Composition for use in microbiota modulation
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
IL271659A (en) Compositions and methods for modulating expression of complement factor B
GB201411197D0 (en) Composition and use thereof
PT3015526T (pt) Composição à base de hidrofluoroolefina e sua utilização
IL246879B (en) Preparations of Epilimod and methods of using them
IL260017A (en) The lyophilized composition for preserving microbiota in the microbiota ecosystem
SG11201605714VA (en) Block copolymer and adhesive composition
HK1245158A1 (zh) 阿吡莫德組合物及其使用方法
HK1231426A1 (zh) 皮膚增白美容組合物
SI3220893T1 (sl) Sestavek na osnovi COQ10
SG11201610353TA (en) Hybrid composition
SG11201702475VA (en) Methods and compositions for modulating th-gm cell function
GB201519326D0 (en) Composition`
GB201411196D0 (en) Composition and use thereof
HK1231379A1 (zh) 毛髮組合物
HK1257847A1 (zh) 化妝品組合物
HK1247082A1 (zh) 化妝品組合物
EP3344738A4 (en) COMPOSITION FOR USE IN OILS
RS56048B1 (sr) Usavršene kompozicije i postupci za fruktoboratne komplekse
PL2990058T3 (pl) Ulepszone kompozycje i sposoby dla kompleksów fruktoboranowych
GB201411371D0 (en) Immunogenic composition
GB201411306D0 (en) Immunogenic composition
GB201404391D0 (en) Novel compositions having use in therapy